Interleukin-2 boosted immune cells but failed to preserve insulin production in the DIABIL-2 trial. Discover what this means for type 1 diabetes.
Read More »Diabetes Hospitalizations Aren’t Just About Heart and Kidney Disease Anymore
Explore why diabetes hospitalizations involve more than heart and kidney disease, including infections, respiratory illness, and mental health.
Read More »Feeding at Night, Dosing by Day: Why Parenteral Nutrition Makes Insulin Management So Difficult
Discover why parenteral nutrition complicates insulin dosing and how CGM-guided adjustments improved glucose control in a small clinical study.
Read More »High Altitude, Low Oxygen, Same CGM? Researchers Put Sensor Accuracy to the Test
New research examines CGM accuracy in hypoxia, including Dexcom G6 and FreeStyle Libre performance during reduced oxygen exposure.
Read More »Type 1 Diabetes Care Just Changed: The 2026 ADA/EASD Update Clinicians Need to Know
The type 1 diabetes consensus 2026 expands guidance on AID, cardiovascular risk, obesity, complications, psychosocial care, and new therapies.
Read More »When a Foot Ulcer Isn’t Just a Foot Problem: The Unexpected Link to Spinal Infection
A large study links diabetic foot ulcers with higher odds of spinal infection, including vertebral osteomyelitis and discitis. Learn the warning signs.
Read More »The First Years After a Type 2 Diabetes Diagnosis May Matter More Than We Thought
Early hyperglycemia may influence cancer risk after type 2 diabetes diagnosis. See what a large cohort study found about early glycemic exposure.
Read More »Numbness Isn’t Always Diabetic Neuropathy: The Metformin-B12 Connection That’s Easy to Miss
Metformin B12 deficiency can cause numbness that resembles diabetic neuropathy. Learn who is at risk, when to test B12, and why early detection matters.
Read More »Pivot Just Got an FDA Update—Here’s What Actually Changed
The Pivot Insulin Delivery System received a new FDA clearance in September 2026. Learn what changed and what clinicians should know.
Read More »Type 2 Diabetes Damages the Pancreas, Or Does It?
New research challenges assumptions about the exocrine pancreas in type 2 diabetes and what pancreatic findings may mean for clinical care.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.